Clinical Trial Abstracts

Additional Information

Competency Area: 
Patient Care and Procedural Skills
Topic Area: 
General Endocrinology
Level of Outcomes: 
Level 1 (Participation)
Activity summary
Course opens: 
07/08/2020
Course expires: 
07/31/2023
Rating: 
0

Disclosures for "Adrenal Medicine – Clinical Applications and New Therapies":

  • Deborah P. Merke, MS, MD - Grant Recipient; Diurnal.
  • Richard J. Auchus, MD,PhD - Advisory Board Member; Corcept Therapeutics, Jansen Pharmaceuticals, Quest Diagnostics, Novartis Pharmaceuticals, Strongbridge Biopharma, Spruce Biosciences, Selenity Therapeutics, Adrenas Therapeutics. Consulting Fee; Corcept Therapeutics, Jansen Pharmaceuticals, Quest Diagnostics, Novartis Pharmaceuticals, Strongbridge Biopharma, Spruce Biosciences, Selenity Therapeutics, Adrenas Therapeutics. Grant Recipient; Millendo Therapeutics, Novartis Pharmaceuticals, Strongbridge Biopharma, Neurocrine Biosciences, Inc. Spruce Biosciences. Research Investigator; Millendo Therapeutics, Novartis Pharmaceuticals, Corcept Therapeutics, Strongbridge Biopharma, Neurocrine Biosciences, Inc., Spruce Biosciences.

Disclosures for "Challenges in Reproductive Endocrinology: Late Breaking Insights":

  • Yee-Ming Chan, MD, PhD - Consulting Fee; Becker Pharmaceuticals.

Disclosures for "Clinical Challenges in Diabetes and Metabolism":

  • Edward M Franek, MD, PhD - Consulting Fee; AstraZeneca, Boehringer Ingelheim, Novo Nordisk, Servier, MSD, Mundipharma, Bioton.
  • Juan Pablo Frias, MD - Advisory Board Member; Sanofi. Consulting Fee; AstraZeneca, Boehringer Ingelheim, Eli Lilly & Company, Merck & Co., Novo Nordisk, Sanofi. Research Investigator; Abbvie, Amgen Inc, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly & Company, Merck & Co., Jansen Pharmaceuticals, Novo Nordisk, Pfizer, Inc., Sanofi. Speaker; Merck & Co., Sanofi.
  • Annah Petek Baykal, BS - None.
  • Kathryn Fantasia, MD - None.

Disclosures for "Mechanisms and Treatment of Obesity in Humans":

  • Aaron S. Kelly: Grant Recipient; AstraZeneca, Study support in the form of drug and placebo. Other; Novo Nordisk, Vivus USA.

Disclosures for "New Frontiers in Bone and Mineral Metabolism":

  • Thomas O Carpenter, MD - Advisory Board Member; Ultragenyx, Inozyme. Consulting Fee; Ultragenyx, Inozyme, Regeneron Pharmaceuticals. Grant Recipient; Ultragenyx. Research Investigator; Ultragenyx.
  • Farzana Perwad, MD - Advisory Board Member; Ultragenyx. Consulting Fee; Ultragenyx. Research Investigator; Ultragenyx.
  • Robert G. Feldman, MD - Advisory Board Member; Amgen Inc. Consulting Fee; Amgen Inc. Research Investigator; Amgen Inc, Biogen, AB Biogenesis, TTP. Speaker; Amgen Inc, Merck.
  • Anne Sophie Sølling, MD - None.

Disclosures for "Thyroid Autoimmunity and Benign Thyroid Disease":

  • Lori J. Wirth: Consulting Fee; Bayer, Inc., Merck, Loxo, Eisai.
  • Roberto Cesareo: None.

Disclosures for "Understanding Pediatric Growth Disorders":

  • Aristides K. Maniatis, MD - Research Investigator; Ascendis Pharma Inc., Pfizer, Inc., Novo Nordisk, OPKO Health, Inc.
  • Cheri L. Deal, MD,PhD - Consulting Fee; Pfizer, Inc.